| Title | Intertrigo-like eruption caused by pegylated liposomal doxorubicin (PLD). | | Author(s) | Sánchez Henarejos P, Ros Martínez S, Marín Zafra GR, Alonso Romero JL, Navarrete Montoya A | | Institution | Department of Medical Oncology, Hospital Universitario Virgen de la Arrixaca, El Palmar, Murcia, Spain. | | Source | Clin Transl Oncol 2009 Jul; 11(7):486-487. | | Abstract | Pegylated liposomal doxorubicin (PLD) is a drug whose use is increasingly common. It has been associated with a lower rate of haematologic and cardiac side effects than its nonencapsulated form. However, mucocutaneous toxicity is quite frequent and can be severe. Here we provide a case report of a patient who developed an intertrigolike eruption during treatment with PLD. | | Language | ENG | | Pub Type(s) | JOURNAL ARTICLE
| | PubMed ID | 19574209 |
|
